A
Intravesical mitomycin
You're currently viewing OncGenius as a guest. To save your results, create an account or log in.
Advertisement
At the NCCN 2022 Annual Conference, Thomas Flaig, MD, Professor of Medicine, Vice Chancellor for Research, University of Colorado Anschutz Medical Campus, and Chair of the NCCN Guidelines Panel for Bladder Cancer, presented information on new treatment options in bladder cancer, as well as updates to the NCCN Guidelines for Bladder Cancer.